Skip to main content
Erschienen in: Journal of Gastroenterology 7/2010

01.07.2010 | Original Article—Alimentary Tract

Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening

verfasst von: Adolfo Parra-Blanco, Antonio Z. Gimeno-García, Enrique Quintero, David Nicolás, Santiago G. Moreno, Alejandro Jiménez, Manuel Hernández-Guerra, Marta Carrillo-Palau, Yoshinobu Eishi, Julio López-Bastida

Erschienen in: Journal of Gastroenterology | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Immunochemical tests show important advantages over chemical-based faecal occult blood tests (FOBT) for colorectal cancer (CRC) screening, but comparison studies are limited. This study was performed to compare the accuracy of a sensitive immunochemical test with the guaiac test for detecting significant neoplasia (advanced adenomas and CRC) in an average-risk population.

Methods

A random sample of 2288 asymptomatic subjects 50–79 years of age was prospectively included. Participants received three cards of the guaiac test, one sample of a latex-agglutination test (haemoglobin cut-off 50 ng/ml), and an invitation to undergo colonoscopy. Test sensitivity, specificity, and positive and negative predictive values (PPV and NPV) were calculated in 1756 compliers.

Results

Immunochemical and guaiac tests were positive in 143 (8.1%) and 62 (3.5%) subjects, respectively. Complete colonoscopy, performed in 402 participants (158 FOBT+ and 244 FOBT−), detected 14 (0.8%) patients with CRC and 49 (2.8%) with advanced adenomas. The immunochemical and guaiac tests for significant colorectal neoplasia showed sensitivities of 61% versus 23.8%, specificities of 95.1% versus 97.7%, PPVs of 43.4% versus 39.0%, and NPVs of 97.5% versus 95.4%, respectively. Proximal significant neoplasms were more frequently detected with the immunochemical test (85% vs. 15%) The relative risk for detecting significant neoplasia was superior in patients with a positive immunochemical test (RR 16.93; CI 7.94–36.10) than with a positive guaiac test (RR 3.34; CI 2.17–5.15).

Conclusion

A sensitive immunochemical test is markedly superior to the guaiac test for detecting significant colorectal neoplasia, and should be considered the first-choice FOBT for CRC screening in the average-risk population.
Literatur
1.
Zurück zum Zitat Keighley MR. Gastrointestinal cancers in Europe. Aliment Pharmacol Ther. 2003;18(Suppl 3):7–30.CrossRefPubMed Keighley MR. Gastrointestinal cancers in Europe. Aliment Pharmacol Ther. 2003;18(Suppl 3):7–30.CrossRefPubMed
2.
Zurück zum Zitat Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7.CrossRefPubMed Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7.CrossRefPubMed
3.
Zurück zum Zitat Kronborg O, Jorgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol. 2004;39:846–51.CrossRefPubMed Kronborg O, Jorgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol. 2004;39:846–51.CrossRefPubMed
4.
Zurück zum Zitat Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71.CrossRefPubMed Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71.CrossRefPubMed
5.
Zurück zum Zitat Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126:1674–80.CrossRefPubMed Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126:1674–80.CrossRefPubMed
6.
Zurück zum Zitat Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–7.CrossRefPubMed Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–7.CrossRefPubMed
7.
Zurück zum Zitat Young GP, St John DJ, Winawer SJ, Rozen P. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol. 2002;97:2499–507.PubMed Young GP, St John DJ, Winawer SJ, Rozen P. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol. 2002;97:2499–507.PubMed
8.
Zurück zum Zitat Young GP. Screening for colorectal cancer: alternative faecal occult blood tests. Eur J Gastroenterol Hepatol. 1998;10:205–12.CrossRefPubMed Young GP. Screening for colorectal cancer: alternative faecal occult blood tests. Eur J Gastroenterol Hepatol. 1998;10:205–12.CrossRefPubMed
9.
Zurück zum Zitat Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsene D, Boutreux S, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut. 2007;56:210–4.CrossRefPubMed Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsene D, Boutreux S, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut. 2007;56:210–4.CrossRefPubMed
10.
Zurück zum Zitat Hoepffner N, Shastri YM, Hanisch E, Rosch W, Mossner J, Caspary WF, et al. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study. Aliment Pharmacol Ther. 2006;23:145–54.CrossRefPubMed Hoepffner N, Shastri YM, Hanisch E, Rosch W, Mossner J, Caspary WF, et al. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study. Aliment Pharmacol Ther. 2006;23:145–54.CrossRefPubMed
11.
Zurück zum Zitat Levi Z, Rozen P, Hazazi R, Vilkin A, Wakef A, Maoz E, et al. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer? Aliment Pharmacol Ther. 2006;24:1475–81.CrossRefPubMed Levi Z, Rozen P, Hazazi R, Vilkin A, Wakef A, Maoz E, et al. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer? Aliment Pharmacol Ther. 2006;24:1475–81.CrossRefPubMed
12.
Zurück zum Zitat Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol. 2005;100:2519–25.CrossRefPubMed Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol. 2005;100:2519–25.CrossRefPubMed
13.
Zurück zum Zitat Nakajima M, Saito H, Soma Y, Sobue T, Tanaka M, Munakata A. Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a case–control study. Br J Cancer. 2003;89:23–8.CrossRefPubMed Nakajima M, Saito H, Soma Y, Sobue T, Tanaka M, Munakata A. Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a case–control study. Br J Cancer. 2003;89:23–8.CrossRefPubMed
14.
Zurück zum Zitat Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 1996;334:155–9.CrossRefPubMed Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 1996;334:155–9.CrossRefPubMed
15.
Zurück zum Zitat Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004;351:2704–14.CrossRefPubMed Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004;351:2704–14.CrossRefPubMed
16.
Zurück zum Zitat Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99:1462–70.CrossRefPubMed Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99:1462–70.CrossRefPubMed
17.
Zurück zum Zitat Castiglione G, Grazzini G, Ciatto S. Guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening. Br J Cancer. 1992;65:942–4.PubMed Castiglione G, Grazzini G, Ciatto S. Guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening. Br J Cancer. 1992;65:942–4.PubMed
18.
Zurück zum Zitat van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82–90.CrossRefPubMed van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82–90.CrossRefPubMed
19.
Zurück zum Zitat Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009;100:1103–10.CrossRefPubMed Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009;100:1103–10.CrossRefPubMed
20.
Zurück zum Zitat Guittet L, Bouvier V, Mariotte N, Vallee JP, Levillain R, Tichet J, et al. Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location. Br J Cancer. 2009;100:1230–5.CrossRefPubMed Guittet L, Bouvier V, Mariotte N, Vallee JP, Levillain R, Tichet J, et al. Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location. Br J Cancer. 2009;100:1230–5.CrossRefPubMed
21.
Zurück zum Zitat Parra-Blanco A, Nicolas-Perez D, Gimeno-Garcia A, Grosso B, Jimenez A, Ortega J, et al. The timing of bowel preparation before colonoscopy determines the quality of cleansing, and is a significant factor contributing to the detection of flat lesions: a randomized study. World J Gastroenterol. 2006;12:6161–6.PubMed Parra-Blanco A, Nicolas-Perez D, Gimeno-Garcia A, Grosso B, Jimenez A, Ortega J, et al. The timing of bowel preparation before colonoscopy determines the quality of cleansing, and is a significant factor contributing to the detection of flat lesions: a randomized study. World J Gastroenterol. 2006;12:6161–6.PubMed
22.
Zurück zum Zitat Fujii T, Hasegawa RT, Saitoh Y, Fleischer D, Saito Y, Sano Y, et al. Chromoscopy during colonoscopy. Endoscopy. 2001;33:1036–41.PubMed Fujii T, Hasegawa RT, Saitoh Y, Fleischer D, Saito Y, Sano Y, et al. Chromoscopy during colonoscopy. Endoscopy. 2001;33:1036–41.PubMed
23.
Zurück zum Zitat Diamond GA. Reverend Bayes’ silent majority. An alternative factor affecting sensitivity and specificity of exercise electrocardiography. Am J Cardiol. 1986;57:1175–80.CrossRefPubMed Diamond GA. Reverend Bayes’ silent majority. An alternative factor affecting sensitivity and specificity of exercise electrocardiography. Am J Cardiol. 1986;57:1175–80.CrossRefPubMed
24.
Zurück zum Zitat Leiner S. Verification bias in screening for prostate cancer. N Engl J Med. 2003;349:1672–3. Leiner S. Verification bias in screening for prostate cancer. N Engl J Med. 2003;349:1672–3.
25.
Zurück zum Zitat Kosinski AS, Barnhart HX. A global sensitivity analysis of performance of a medical diagnostic test when verification bias is present. Stat Med. 2003;22:2711–21.CrossRefPubMed Kosinski AS, Barnhart HX. A global sensitivity analysis of performance of a medical diagnostic test when verification bias is present. Stat Med. 2003;22:2711–21.CrossRefPubMed
26.
Zurück zum Zitat Murphy JR. The relationship of relative risk and positive predictive value in 2 × 2 tables. Am J Epidemiol. 1983;117:86–9.PubMed Murphy JR. The relationship of relative risk and positive predictive value in 2 × 2 tables. Am J Epidemiol. 1983;117:86–9.PubMed
27.
Zurück zum Zitat Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev. 2007;1:CD001216.PubMed Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev. 2007;1:CD001216.PubMed
28.
Zurück zum Zitat Castiglione G, Sala P, Ciatto S, Grazzini G, Mazzotta A, Rossetti C, et al. Comparative analysis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions. Eur J Cancer Prev. 1994;3:399–405.CrossRefPubMed Castiglione G, Sala P, Ciatto S, Grazzini G, Mazzotta A, Rossetti C, et al. Comparative analysis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions. Eur J Cancer Prev. 1994;3:399–405.CrossRefPubMed
29.
Zurück zum Zitat Castiglione G, Zappa M, Grazzini G, Mazzotta A, Biagini M, Salvadori P, et al. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. Br J Cancer. 1996;74:141–4.PubMed Castiglione G, Zappa M, Grazzini G, Mazzotta A, Biagini M, Salvadori P, et al. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. Br J Cancer. 1996;74:141–4.PubMed
30.
Zurück zum Zitat Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer. 2008;44:2254–8.CrossRefPubMed Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer. 2008;44:2254–8.CrossRefPubMed
31.
Zurück zum Zitat Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–8.PubMed Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–8.PubMed
32.
Zurück zum Zitat Zappa M, Castiglione G, Paci E, Grazzini G, Rubeca T, Turco P, et al. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience. Int J Cancer. 2001;92:151–4.CrossRefPubMed Zappa M, Castiglione G, Paci E, Grazzini G, Rubeca T, Turco P, et al. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience. Int J Cancer. 2001;92:151–4.CrossRefPubMed
33.
Zurück zum Zitat Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006;107:2152–9.CrossRefPubMed Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006;107:2152–9.CrossRefPubMed
34.
Zurück zum Zitat Hol L, Van Leerdam ME, Van Ballegooijen M, Van Vuuren AJ, Van Dekken H, Reijerink JC, et al. Screening for colorectal cancer; randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59:62–68. Hol L, Van Leerdam ME, Van Ballegooijen M, Van Vuuren AJ, Van Dekken H, Reijerink JC, et al. Screening for colorectal cancer; randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59:62–68.
35.
Zurück zum Zitat Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162–8.CrossRefPubMed Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162–8.CrossRefPubMed
36.
Zurück zum Zitat Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146:244–55.PubMed Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146:244–55.PubMed
37.
Zurück zum Zitat Subramanian S, Klosterman M, Amonkar MM, Hunt TL. Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004;38:536–50.CrossRefPubMed Subramanian S, Klosterman M, Amonkar MM, Hunt TL. Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004;38:536–50.CrossRefPubMed
38.
Zurück zum Zitat Gimeno-Garcia AZ, Quintero E, Nicolas-Perez D, Parra-Blanco A, Jimenez-Sosa A. Impact of an educational video-based strategy on the behavior process associated with colorectal cancer screening: a randomized controlled study. Cancer Epidemiol. 2009;33:216–22.CrossRefPubMed Gimeno-Garcia AZ, Quintero E, Nicolas-Perez D, Parra-Blanco A, Jimenez-Sosa A. Impact of an educational video-based strategy on the behavior process associated with colorectal cancer screening: a randomized controlled study. Cancer Epidemiol. 2009;33:216–22.CrossRefPubMed
39.
Zurück zum Zitat Irwig L, Bossuyt P, Glasziou P, Gatsonis C, Lijmer J. Designing studies to ensure that estimates of test accuracy are transferable. BMJ. 2002;324:669–71.CrossRefPubMed Irwig L, Bossuyt P, Glasziou P, Gatsonis C, Lijmer J. Designing studies to ensure that estimates of test accuracy are transferable. BMJ. 2002;324:669–71.CrossRefPubMed
Metadaten
Titel
Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening
verfasst von
Adolfo Parra-Blanco
Antonio Z. Gimeno-García
Enrique Quintero
David Nicolás
Santiago G. Moreno
Alejandro Jiménez
Manuel Hernández-Guerra
Marta Carrillo-Palau
Yoshinobu Eishi
Julio López-Bastida
Publikationsdatum
01.07.2010
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 7/2010
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-010-0214-8

Weitere Artikel der Ausgabe 7/2010

Journal of Gastroenterology 7/2010 Zur Ausgabe

Original Article—Liver, Pancreas, and Biliary Tract

Bezafibrate for the treatment of primary sclerosing cholangitis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.